andere Bezeichnungen
- Brechreiz
- Würgreiz
Übelkeit
Nausea ist eine Befindlichkeitsstörung, die auch als „flaues“ Gefühl in der Magengegend und Brechreiz bezeichnet wird. Sie kann aber auch als nicht lokalisierbares Gemeingefühl auftreten oder als Kombination von beidem, d. h. als Gefühl in der Magengegend und als Gemeingefühl (allgemeine Übelkeit).
Hauptwirksame Cannabinoide
- CBD (Cannabidiol)
- CBDa
- Δ⁹-THC
Studien/Artikel zur Behandlung von Übelkeit mit Cannabis-Medikation
-
- Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.
- Managing Nausea with Cannabis.
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.
- Beneficial Effect of Medical Cannabis in the Treatment of a Pharmacoresistant Nausea Associated with a Somatoform Disorder in a Patient with Post-Polio Syndrome.
- Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.
- Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
- Regulation of nausea and vomiting by cannabinoids.
- Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats.
- Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
- Effect of combined oral doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models.
- Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
- A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
- The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy.
- Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
- Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
- Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
- delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
- Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
- Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
- Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
- Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
- Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
- Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine.
- THC or Compazine for the cancer chemotherapy patient–the UCLA study. Part II: Patient drug preference.
- Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.
- Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
- Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
- Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
- Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study.
- A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
- Nabilone: an alternative antiemetic for cancer chemotherapy.
- Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
- Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin.
- A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
- A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
- Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
- Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
- A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
- Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
- Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy.
- A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy.
- Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis.
- American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
- Use of medical marijuana for treatment of severe intractable nausea after laparoscopic Roux-en-Y gastric bypass surgery.
- Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac.
- Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.
- Clinical Studies and Case Reports
- Link Wikipedia (DE)